Showing results (951-960 of 1,230) with videos related to
Sort By:
Pageof 123
Schweizer Archiv Fur Tierheilkunde|May 7, 2013
Effects of different types of solid feeds on health status and performance of Swiss veal calves. I. Basic feeding with milk by-productsB Räber, T Kaufmann, G Regula, et al.Structure (London, England : 1993)|December 20, 2016
Binding of Myomesin to Obscurin-Like-1 at the Muscle M-Band Provides a Strategy for Isoform-Specific Mechanical ProtectionStefano Pernigo, Atsushi Fukuzawa, Amy E M Beedle, et al.Acta Neurochirurgica. Supplement|April 25, 2009
Intracranial pressure in patients with sepsisD Pfister, B Schmidt, P Smielewski, et al.Angewandte Chemie (International Ed. in English)|October 15, 2014
Direct evidence for a peroxide intermediate and a reactive enzyme-substrate-dioxygen configuration in a cofactor-free oxidaseSoi Bui, David von Stetten, Pablo G Jambrina, et al.Veterinary Microbiology|May 16, 2022
Antimicrobial susceptibility in E. coli and Pasteurellaceae at the beginning and at the end of the fattening process in veal calves: Comparing 'outdoor veal calf' and conventional operationsJ Becker, V Perreten, A Steiner, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1987
Single- and multiple-dose pharmacokinetics of nufenoxole in healthy human subjectsR D Brownsill, M P Hiley, C W Vose, et al.Molecular Therapy. Advances|May 20, 2026
Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCSMichel A Steiner, Catherine Vaillant, Marco Garzotti, et al.Preventive Medicine Reports|December 7, 2016
Potentially preventable hospitalizations for acute and chronic conditions in Alaska, 2010-2012Prabhu P Gounder, Sara M Seeman, Robert C Holman, et al.The Journal of Bone and Joint Surgery. American Volume|August 19, 2016
Impact of Race/Ethnicity and Socioeconomic Status on Risk-Adjusted Hospital Readmission Rates Following Hip and Knee ArthroplastyGrant R Martsolf, Marguerite L Barrett, Audrey J Weiss, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative GroupH Pehamberger, H P Soyer, A Steiner, et al.Pageof 123